Showing results (481-490 of 493) with videos related to

Sort By:
Pageof 50
Scientific Reports|November 3, 2023
Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithmsHugh G Pemberton, Jiaming Wu, Ivar Kommers, et al.
Seizure|April 9, 2019
Surgical resection of cavernous angioma located within eloquent brain areas: International survey of the practical management among 19 specialized centersMarc Zanello, Bernhard Meyer, Megan Still, et al.
Blood|April 24, 2020
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myelomaCristina Perez, Cirino Botta, Aintzane Zabaleta, et al.
Neurosurgery|March 30, 2019
Predictors of Epileptic Seizures and Ability to Work in Supratentorial Cavernous Angioma Located Within Eloquent Brain AreasMarc Zanello, John R Goodden, Henry Colle, et al.
Cancer|May 12, 2026
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world studyFrancesca Palandri, Monia Marchetti, Elena M Elli, et al.
American Journal of Hematology|November 22, 2025
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 PatientsMatteo Molica, Gema Miralles, Richard Dillon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2020
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancerJenna H Newman, C Brent Chesson, Nora L Herzog, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Hematological Oncology|December 29, 2025
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World StudyErnesto Vigna, Enrica Antonia Martino, Annalisa Pitino, et al.
Blood Advances|January 7, 2026
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian CohortEnrica Antonia Martino, Annalisa Pitino, Ernesto Vigna, et al.
Pageof 50